share_log

Novo Integrated Sciences | 4: Statement of changes in beneficial ownership of securities-Officer David Christopher Mehlin

Novo Integrated Sciences | 4: Statement of changes in beneficial ownership of securities-Officer David Christopher Mehlin

Novo Integrated Sciences | 4：持股變動聲明-高管 David Christopher Mehlin
美股SEC公告 ·  09/12 18:09
牛牛AI助理已提取核心訊息
David Christopher Mehlin, the Chief Operating Officer of Novo Integrated Sciences, Inc., has engaged in a transaction involving the company's stock on January 16, 2024. The transaction pertained to Class A Common Stock, with Mehlin directly holding a total of 8,195 shares after the event. The action reflects changes in the direct holdings of the company's securities by a key executive and is relevant for current and potential investors monitoring insider activity.
David Christopher Mehlin, the Chief Operating Officer of Novo Integrated Sciences, Inc., has engaged in a transaction involving the company's stock on January 16, 2024. The transaction pertained to Class A Common Stock, with Mehlin directly holding a total of 8,195 shares after the event. The action reflects changes in the direct holdings of the company's securities by a key executive and is relevant for current and potential investors monitoring insider activity.
2024年1月16日，諾沃綜合科學公司的首席運營官David Christopher Mehlin參與了一筆涉及公司股票的交易。這次交易涉及A類普通股，Mehlin在事件發生後直接持有8195股。該行動反映了公司主要高管對公司證券直接持有量的變動，對正在監控內幕交易的現有和潛在投資者來說具有重要意義。
2024年1月16日，諾沃綜合科學公司的首席運營官David Christopher Mehlin參與了一筆涉及公司股票的交易。這次交易涉及A類普通股，Mehlin在事件發生後直接持有8195股。該行動反映了公司主要高管對公司證券直接持有量的變動，對正在監控內幕交易的現有和潛在投資者來說具有重要意義。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。